PapersPMID:20092985
A randomized double blind placebo controlled clinical evaluation of extract of Andrographis paniculata (KalmCold) in patients with uncomplicated upper respiratory tract infection.
No finding here moved its endpoint.
What did not
1 findingHow to read these marks →“In both placebo and KalmCold treated groups, there were only a few minor adverse effects with no significant difference in occurrence (Z = 0.63; p > 0.05).”
- Study
- RCT
- Dose studied
- 200 mg/day
- Population
- Patients with uncomplicated upper respiratory tract infection, both sexes
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- patients of both sexes with uncomplicated upper respiratory tract infection (URTI)
- Participants
- 223
- Comparator
- placebo
- Duration
- not reported
- Endpoints measured
- 15